Applied BioCode (TPE:6598) E10: NT$-2.83 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6598 Applied BioCode Corp TPE:6598
74 GF Score
Price NT$31.50
GF Value NT$27.79
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Applied BioCode E10?

Applied BioCode TPE:6598 +0.48% 74 E10 is NT$-2.83 as of Mar. 2026. GuruFocus rates TPE:6598 with a GF Score™ of 74/100 and a GF Value™ of NT$27.79 (Modestly Overvalued). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Applied BioCode's adjusted earnings per share data for the three months ended in Mar. 2026 was NT$0.200. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$-2.83 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 7.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Applied BioCode was 7.90% per year. The lowest was 7.20% per year. And the median was 7.55% per year.

As of today (2026-08-04), Applied BioCode's current stock price is NT$31.50. Applied BioCode's E10 for the quarter that ended in Mar. 2026 was NT$-2.83. Applied BioCode's Shiller PE Ratio of today is .


Applied BioCode  (TPE:6598) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Applied BioCode E10 Related Terms


Applied BioCode E10 Historical Data

* Premium members only.

The historical data trend for Applied BioCode's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Applied BioCode E10 Chart

Applied BioCode Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Applied BioCode Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -2.83

TPE:6598 vs ABT, SYK, MDT: E10 Comparison

For the Medical Devices subindustry, Applied BioCode's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied BioCode Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Applied BioCode's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Applied BioCode's Shiller PE Ratio falls into.


TPE:6598
74GF Score
Applied BioCode Corp TPE:6598
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Applied BioCode E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Applied BioCode's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.2/330.2130*330.2130
=0.200

Current CPI (Mar. 2026) = 330.2130.

Applied BioCode Quarterly Data

per share eps CPI Adj_EPS
201212 0.000 229.601 0.000
201312 0.000 233.049 0.000
201412 0.000 234.812 0.000
201512 0.000 236.525 0.000
201606 0.000 241.018 0.000
201612 0.000 241.432 0.000
201706 0.000 244.955 0.000
201712 0.000 246.524 0.000
201806 0.000 251.989 0.000
201809 -1.446 252.439 -1.891
201812 -1.059 251.233 -1.392
201903 -1.143 254.202 -1.485
201906 -1.200 256.143 -1.547
201909 -1.049 256.759 -1.349
201912 -0.728 256.974 -0.935
202003 -0.586 258.115 -0.750
202006 -1.058 257.797 -1.355
202009 -0.265 260.280 -0.336
202012 0.614 260.474 0.778
202103 -0.274 264.877 -0.342
202106 -0.633 271.696 -0.769
202109 -0.709 274.310 -0.853
202112 -0.293 278.802 -0.347
202203 -0.851 287.504 -0.977
202206 -0.369 296.311 -0.411
202209 -0.510 296.808 -0.567
202212 -0.406 296.797 -0.452
202303 -0.586 301.836 -0.641
202306 -0.709 305.109 -0.767
202309 -0.530 307.789 -0.569
202312 -0.110 306.746 -0.118
202403 -0.770 312.332 -0.814
202406 -0.610 314.175 -0.641
202409 -0.800 315.301 -0.838
202412 -0.680 315.605 -0.711
202503 -0.350 319.799 -0.361
202506 -0.660 322.561 -0.676
202509 -0.330 324.800 -0.335
202512 -0.630 324.054 -0.642
202603 0.200 330.213 0.200

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$-2.83 mean?
Applied BioCode (TPE:6598) has a E10 of NT$-2.83 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Applied BioCode and its competitors.
Is Applied BioCode's E10 too high?
Applied BioCode's current E10 is NT$-2.83. Overall, Applied BioCode has a GF Score™ of 74/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Applied BioCode's E10 compare to ABT and SYK?
Applied BioCode's E10 of NT$-2.83 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Applied BioCode and its competitors. Applied BioCode's current E10 is NT$-2.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Applied BioCode stock overvalued right now?
Based on GuruFocus' analysis, Applied BioCode (TPE:6598) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$27.79, compared to a current price of NT$31.50 — trading 13.4% above its estimated fair value. The current E10 is NT$-2.83. Applied BioCode's overall GF Score™ is 74/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Applied BioCode (TPE:6598), the current E10 is NT$-2.83 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Applied BioCode (TPE:6598) Overvalued in 2026?

Based on GuruFocus' analysis, Applied BioCode stock appears to be overvalued. The current stock price of NT$31.50 is trading 13.4% above its estimated GF Value™ of NT$27.79. GuruFocus considers Applied BioCode to be Modestly Overvalued.

Key valuation signals for TPE:6598:

  • E10: NT$-2.83
  • GF Value™: NT$27.79 vs. price of NT$31.50 (13.4% above fair value)
  • GF Score™: 74/100 with 7 warning signs

No single metric tells the full story. See the TPE:6598 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Applied BioCode Business Description

Address 12130 Mora Dr., Unit 2, Santa Fe Springs, CA, USA, 90670
Applied BioCode Corp is engaged in designing, developing, manufacturing, and commercializing multiplex testing products for the in-vitro diagnostics market. The company's in-vitro diagnostic products focus on the molecular infectious disease segment of the market with assays that detect pathogens for gastrointestinal tract infections, respiratory infections, and sexually transmitted infections. The firm's products include barcoded magnetic bead technology (BMB). The BMB technology and detection systems assist in the development of multiplexed nucleic acids or protein detection assays. The company also develops applications for other areas of the diagnostics industry including life science research, agricultural testing, and veterinary markets.
74GF Score

Get the complete analysis for TPE:6598

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$31.50
Price
NT$27.79
GF Value